Immediate Impact
52 standout
Citing Papers
Cancer statistics, 2025
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Yongwei Su being referenced
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
2020
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yongwei Su | 545 | 294 | 80 | 126 | 26 | 662 | |
| Cristina Panuzzo | 391 | 305 | 118 | 87 | 46 | 618 | |
| R J Jaju | 381 | 405 | 83 | 72 | 22 | 751 | |
| Daniel H. Wiseman | 512 | 328 | 93 | 78 | 45 | 823 | |
| Tong Sun | 362 | 193 | 106 | 272 | 22 | 688 | |
| Franz X. Schaub | 491 | 190 | 127 | 85 | 23 | 672 | |
| Naoko Watanabe‐Okochi | 477 | 440 | 91 | 93 | 31 | 800 | |
| Amitava Sengupta | 453 | 232 | 113 | 73 | 37 | 700 | |
| Ekatherine Asatiani | 354 | 207 | 116 | 59 | 19 | 647 | |
| Ruriko Tanaka | 351 | 339 | 156 | 48 | 23 | 713 | |
| Shamika Ketkar | 354 | 182 | 31 | 137 | 21 | 608 |
All Works
Login with ORCID to disown or claim papers
Loading papers...